Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $22.4 million.

  • Anaptysbio's Non-Current Assets fell 4982.23% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.7 million, marking a year-over-year decrease of 383.22%. This contributed to the annual value of $52.0 million for FY2024, which is 1405.8% up from last year.
  • Anaptysbio's Non-Current Assets amounted to $22.4 million in Q3 2025, which was down 4982.23% from $43.3 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Non-Current Assets registered a high of $168.1 million during Q3 2022, and its lowest value of $9.3 million during Q1 2021.
  • Over the past 5 years, Anaptysbio's median Non-Current Assets value was $58.9 million (recorded in 2025), while the average stood at $72.2 million.
  • In the last 5 years, Anaptysbio's Non-Current Assets plummeted by 8253.6% in 2021 and then soared by 111417.03% in 2022.
  • Quarter analysis of 5 years shows Anaptysbio's Non-Current Assets stood at $89.2 million in 2021, then soared by 82.95% to $163.2 million in 2022, then crashed by 72.08% to $45.6 million in 2023, then increased by 14.06% to $52.0 million in 2024, then tumbled by 56.8% to $22.4 million in 2025.
  • Its Non-Current Assets stands at $22.4 million for Q3 2025, versus $43.3 million for Q2 2025 and $58.9 million for Q1 2025.